Open Access Email this article to a friend

Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation

Alessandra Fabi*, Giulio Metro, Michelangelo Russillo, Antonello Vidiri, Carmine M Carapella, Marta Maschio, Francesco Cognetti, Bruno Jandolo, Maria A Mirri, Isabella Sperduti, Stefano Telera, Mariantonia Carosi and Andrea Pace

BMC Cancer 2009, 9:101 doi:10.1186/1471-2407-9-101

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Cancer's emails?